REQUEST A DEMO
Total
USD $0.00
Search more companies

Distribuidora y Comercializadora Novelpharm Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Distribuidora y Comercializadora Novelpharm Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Distribuidora y Comercializadora Novelpharm Sas is a company based in Colombia, with its head office in Bogota D.C.. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. Distribuidora y Comercializadora Novelpharm Sas was incorporated on March 16, 2007. It currently has a total number of 3 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 39.85% in 2023. A negative growth of 11.4% was recorded in its total assets.

Headquarters
15 # 124 17 Of 610
Bogota D.C.; Bogota D.C; Postal Code: 1012

Contact Details: Purchase the Distribuidora y Comercializadora Novelpharm Sas report to view the information.

Basic Information
Total Employees:
Purchase the Distribuidora y Comercializadora Novelpharm Sas report to view the information.
Outstanding Shares:
Purchase the Distribuidora y Comercializadora Novelpharm Sas report to view the information.
Incorporation Date:
March 16, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Distribuidora y Comercializadora Novelpharm Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
39.85%
Total operating revenue
39.85%
Operating profit (EBIT)
N/A
Total assets
-11.4%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Quick Ratio
0.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?